Kyowa Kirin (KYKOF) Set to Post Earnings on Monday

Kyowa Kirin (OTCMKTS:KYKOF) will likely be issuing its results after the market closes on Monday, November 2nd. Analysts expect the company to post earnings of $0.2511 per share and revenue of $796.43 million for the quarter.

Kyowa Kirin Price Performance

Shares of OTCMKTS KYKOF opened at $16.75 on Friday. Kyowa Kirin has a fifty-two week low of $4.20 and a fifty-two week high of $16.75. The business has a 50-day simple moving average of $14.93 and a two-hundred day simple moving average of $14.61.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group cut Kyowa Kirin to a “hold” rating in a report on Tuesday, September 8th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Kyowa Kirin has an average rating of “Reduce”.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. is a Japan-based specialty pharmaceutical company that researches, develops, manufactures and markets prescription medicines. The company focuses on therapies for areas including oncology, immunology, nephrology, the central nervous system and rare diseases, with an emphasis on biologics and other innovative treatments.

Its products include Poteligeo (mogamulizumab), an antibody used in certain hematologic cancers and cutaneous T-cell lymphomas, and Crysvita (burosumab), a treatment for disorders involving abnormal phosphate regulation.